Insulet Corp.
PODD NASDAQHealthcare ★★★★★Latest Earnings
Date
Aug 5, 2026
ET
EPS Est.
1.47
EPS Actual
1.66
Revenue Est.
$787.4M
Revenue Actual
$801.7M
Next Earnings Report
Date
Nov 5, 2026 · Thu
Time
Pre-market
Fiscal Period
FY2026 Q3
EPS Est.
1.59
Revenue Est.
$833.9M
Company Overview
Insulet Corp. (ticker PODD) is listed on NASDAQ with a market cap of about $10.26B. Its next earnings report (FY2026 Q3) is expected on Nov 5, 2026 (ET), Pre-market, with consensus EPS of 1.59. In the last 15 reported quarters, EPS beat consensus estimates 14 times.
Actual EPS TrendRecently15Term · Feb 23, 2023 → Aug 5, 2026
Feb 23, 2023Range: 0.23 ~ 1.66Aug 5, 2026
Earnings History
| Date | Fiscal Period | EPS Est. | EPS Actual | Revenue Est. | Revenue Actual |
|---|---|---|---|---|---|
| Aug 5, 2026 | -- | 1.47 | 1.66 | $787.4M | $801.7M |
| May 6, 2026 | -- | 1.19 | Above forecast↑1.42 | $729.9M | $761.7M |
| Feb 18, 2026 | -- | 1.47 | 1.55 | $769M | $783.8M |
| Nov 6, 2025 | -- | 1.14 | 1.24 | $678.4M | $706.3M |
| Aug 7, 2025 | -- | 0.92 | Above forecast↑1.17 | $614.2M | $649.1M |
| May 8, 2025 | -- | 0.79 | Above forecast↑1.02 | $543.3M | $569M |
| Feb 20, 2025 | -- | 1.00 | 1.15 | $582.5M | $597.5M |
| Nov 7, 2024 | -- | 0.76 | Above forecast↑0.90 | $519.5M | $372.6M |
| Aug 8, 2024 | -- | 0.56 | 0.55 | $488M | $488.5M |
| May 9, 2024 | -- | 0.39 | Above forecast↑0.73 | $424.1M | $441.7M |
| Feb 22, 2024 | -- | 0.66 | Above forecast↑1.40 | $461.1M | $509.8M |
| Nov 2, 2023 | -- | 0.40 | Above forecast↑0.71 | $414.4M | $432.7M |
| Aug 8, 2023 | -- | 0.26 | Above forecast↑0.38 | $385M | $396.5M |
| May 4, 2023 | -- | 0.11 | Above forecast↑0.23 | $330.9M | $358.1M |
| Feb 23, 2023 | -- | 0.24 | 0.25 | $332.4M | $369.7M |
Original Filings (SEC)
10-Q2026-08-05 ↗
8-K2026-08-05 ↗
8-K2026-06-25 ↗
8-K2026-05-26 ↗
8-K2026-05-21 ↗
10-Q2026-05-06 ↗
8-K2026-05-06 ↗
8-K2026-04-29 ↗
Links point to the company's original filings on the U.S. Securities and Exchange Commission (SEC) website.
Report dates are US trading days (Eastern Time); EPS and revenue estimates are market consensus, in USD. This page is for reference only and does not constitute investment advice.
